Assessment and differential diagnosis of iron-deficiency anaemia during pregnancy

Clinical Drug Investigation

Volumn 19, Issue SUPPL. 1, 2000, Pages 21-27

  Breymann, Christian ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FERRITIN; FOLIC ACID; HEMOGLOBIN; IRON; TRANSFERRIN;

DIFFERENTIAL DIAGNOSIS; FEMALE; GESTATIONAL AGE; HUMAN; IRON DEFICIENCY ANEMIA; KIDNEY FAILURE; MALARIA; PLASMA VOLUME; PREGNANCY; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; THALASSEMIA;

EID: 0034079062     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200019001-00003     Document Type: Review

References (28)

1. Centers for Disease Control. Criteria for anemia in children and childbearing-aged women. MMWR Morb Mortal Wkly Rep 1989; 38 (22): 400-4
2. Bridges K. Iron Imbalance during pregnancy. In: Bern M, Frigoletto F, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, 1990: 113-28
3. Guidozzi F, Patel R, Mc Phail A. A prospective study of iron status in white and black pregnant women in an urban hospital. S Afr Med J 1995; 85 (3): 171-3
4. Milman N, Agger A, Nielsen O. Iron status markers and serum erythropoietin in 120 mothers and newborn infants; effect of iron supplementation in normal pregnancy. Acta Obstet Gynecol Scand 1994; 73: 200-4
5. Hercberg S, Galan P, Preziosi P, et al. Consequences of iron deficiency in pregnant women: current issues. Clin Drug Invest 1999; 18 Suppl. 1: 1-7
6. Hallberg L. Prevention of iron deficiency. Baillieres Clin Hematol 1994; 7 (4): 805-14
7. Seefried B. Vergleichende Untersuchung von hämatologischen Parametern und des Eisenstoffwechsels von Müttern und Neugeborenen unter Anwendung der Retikulozytenflowzytometrie [dissertation]. Klinik f. Geburtshilfe, Universität Zürich, 1995
8. Kaufer M, Casanueva E. Relation of prepregnancy serum ferritin levels to hemoglobin levels throughout pregnancy. Eur J Clin Nutr 1990; 44: 709-15
9. Cook J, Finch C, Smith N. Evaluation of the iron status of a population. Blood 1976; 48: 449-55
10. Gibson R. Assessement of iron status. In: Gibson R, editor. Principles of nutritional assessement. New York: Oxford University Press, 1990: 349-76
11. Cook J, Finch C, Smith N: Evaluation of the iron status of a population. Blood 1976; 48: 449-55
12. Goepel E, Ulmer H, Neth R. Premature labor contractions and the value of serum ferritin during pregnancy. Gynaecol Obstet Invest 1988; 26: 265-73
13. Perewusnyk G, Guntermann H, Breymann C, et al. Bedeutung von Neopterin, Ferritin und sTfR bei der peripartalen Beurteilung des Eisenstatus. Gynäkol Geburtshilfliche Rundsch 1999; 39: 156
14. Schaefer R, Schaefer L. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy. J Perinat Med 1995; 23: 83-8
15. Breymann C, Perewusnyk G, Guntermann H, et al. Unrecognised iron deficiency in critical illness. Lancet 1999; 353 (9155): 841-2
16. Kraffi A, Breymann C, Schneider J, et al. Neopterin und sTfR bei vermeintlicher "schwerer Eisenmangelanämie" in der Schwangerschaft. Gynäkol Geburtshilfliche Rundsch 1999; 39: 145
17. Breymann C, Major A, Richter C, et al. Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study. J Perinat Med 1995; 23: 89-98
18. Beguin Y. Lipcsei G, Thoumsin H, et al. Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood 1991; 78: 89-91
19. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89 (3): 1052-7
20. ACOG. Hemoglobinopathies in pregnancy. ACOG Tech Bull 1996 (220): 1-9
21. Charache S. Hemoglobinopathies. In: Bern M, Frigoletto F, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, 1990: 171-81
22. Breymann C, Fibach E, Visca E, et al. Induction of fetal haemoglobin synthesis with rhEPO in anemic patients with heterozygous beta-thalassaemia during pregnancy. J Matern Fet Med 1999; 8: 1-7
23. McCalla C. Sickle cell disease in pregnancy. Postgrad Obstet Gynecol 1994; 14 (3): 1-5
24. Warth J. Sickle cell disease. In: Bern M, Frigoletto F, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, 1990: 183-97
25. Fuchs D, Zangerle R, Dworzak E, et al. Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol 1993; 50: 90-4
26. Spivak J. Serum immunoreactive erythropoietin in health and disease. J Perinat Med 1995, 23: 13-7
27. Rosenlöf K, Kivivuori S, Riska C, et al. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis. Clin Nephrol 1995; 43 (4): 249-55
28. Braga J, Marques R, Branco A, et al. Maternal and perinatal implications of the use of human recombinant erythropoietin. Acta Obstet Gynecol Scand 1996; 75: 449-53